Recombinant PDCD1 (Balstilimab Biosimilar) antibody

Catalog No. ABIN7676067

The Human Monoclonal anti-PDCD1 (Balstilimab Biosimilar) antibody is suitable to detect PDCD1 (Balstilimab Biosimilar) in samples from Human. It has been validated for ELISA, BLI, FACS, Func and SPR.

Quick Overview for Recombinant PDCD1 (Balstilimab Biosimilar) antibody (ABIN7676067)

Target: PDCD1 (Balstilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This PDCD1 (Balstilimab Biosimilar) antibody is un-conjugated

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-PDCD1 (Balstilimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-PDCD1 / PD-1 / CD279 Reference Antibody (balstilimab)

Characteristics: Anti-PDCD1 / PD-1 / CD279 Reference Antibody (balstilimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for PDCD1 (Balstilimab Biosimilar)

Target: PDCD1 (Balstilimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: Q15116